Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation

Rodolphe Besancenot, Damien Roos-Weil, Carole Tonetti, Hadjer Abdelouahab, Catherine Lacout, Florence Pasquier, Christophe Willekens, Philippe Rameau, Yann Lecluse, Jean-Baptiste Micol, Stefan N. Constantinescu, William Vainchenker, Eric Solary, Stéphane Giraudier

Blood (2014) 124 (13): 2104–2115.

https://doi.org/10.1182/blood-2014-03-559815

Published: 2014

Includes: Supplemental data

Journal Articles

Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes

Christian Pecquet, Carmen C. Diaconu, Judith Staerk, Michael Girardot, Caroline Marty, Yohan Royer, Jean-Philippe Defour, Alexandra Dusa, Rodolphe Besancenot, Stephane Giraudier, Jean-Luc Villeval, Laurent Knoops, Pierre J. Courtoy, William Vainchenker, Stefan N. Constantinescu

Blood (2012) 119 (20): 4625–4635.

https://doi.org/10.1182/blood-2011-08-372524

Published: 2012

Includes: Supplemental data

Journal Articles

Interferon-Alpha Preferentially Targets JAK2V617F-Positive Rather Than Wild-Type Early Progenitor Cells in Myeloproliferative Disorders.

Florence Pasquier, Carole Tonetti, Rodolphe Besancenot, Bruno Cassinat, Pharm.D, Jean-Jacques Kiladjian, MD, PhD, Olivier Herault, MD, PhD, MSc, Philippe Rameau, Catherine Lacout, Jean-Luc Villeval, William Vainchenker, MD, PhD, Ronan Chaligné, Stephane Giraudier

Blood (2009) 114 (22): 436.

https://doi.org/10.1182/blood.V114.22.436.436

Published: 2009

Journal Articles

SOCS3 Promoter Methylation Is Not Involved in Primitive Myelofibrosis Megakaryocytic Spontaneous Growth

Ronan Chaligné, Carole Tonetti, Rodolphe Besancenot, Jean-Jacques Kiladjian, Gerard Socie, Dominique Bordessoule, William Vainchenker, Stéphane Giraudier

Blood (2008) 112 (11): 3716.

https://doi.org/10.1182/blood.V112.11.3716.3716

Published: 2008

Journal Articles

Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis

Ronan Chaligné, Chloé James, Carole Tonetti, Rodolphe Besancenot, Jean Pierre Le Couédic, Fanny Fava, Fréderic Mazurier, Isabelle Godin, Karim Maloum, Frédéric Larbret, Yann Lécluse, William Vainchenker, Stéphane Giraudier

Blood (2007) 110 (10): 3735–3743.

https://doi.org/10.1182/blood-2007-05-089003

Published: 2007

Journal Articles

Evidence That the MPL 515L and 515K Mutations Occur in a Lympho-Myeloid Progenitor in Idiopathic Myelofibrosis and Are Associated with TPO Hypersensitivity.

Ronan Chaligne, Jean-Pierre Le Couedic, sRA, Carole Tonetti, sRA, Rodolphe Besancenot, MD, Orianne Wagner-Ballon, MD, PhD, Najet Debili, PhD, William Vainchenker, MD, PhD, Stephane Giraudier, MD, PhD

Blood (2006) 108 (11): 117.

https://doi.org/10.1182/blood.V108.11.117.117

Published: 2006

NARROW

JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation

Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes

Interferon-Alpha Preferentially Targets JAK2V617F-Positive Rather Than Wild-Type Early Progenitor Cells in Myeloproliferative Disorders.

SOCS3 Promoter Methylation Is Not Involved in Primitive Myelofibrosis Megakaryocytic Spontaneous Growth

Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis

Evidence That the MPL 515L and 515K Mutations Occur in a Lympho-Myeloid Progenitor in Idiopathic Myelofibrosis and Are Associated with TPO Hypersensitivity.

Email alerts

ASH Publications

American Society of Hematology

JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation

Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes

Interferon-Alpha Preferentially Targets JAK2V617F-Positive Rather Than Wild-Type Early Progenitor Cells in Myeloproliferative Disorders.

SOCS3 Promoter Methylation Is Not Involved in Primitive Myelofibrosis Megakaryocytic Spontaneous Growth

Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis

Evidence That the MPL 515L and 515K Mutations Occur in a Lympho-Myeloid Progenitor in Idiopathic Myelofibrosis and Are Associated with TPO Hypersensitivity.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only